Jubilant Ingrevia Limited (NSE:JUBLINGREA)
735.00
+6.55 (0.90%)
Jul 31, 2026, 3:30 PM IST
Jubilant Ingrevia Financials Overview
Financials in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
| Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Revenue Revenue Growth | 46,505 | 43,881 | 41,776 | 41,358 | 47,727 | 49,494 |
Revenue Growth | 10.96% | 5.04% | 1.01% | -13.35% | -3.57% | 623.45% |
Gross Profit Gross Profit Growth | 17,902 | 16,755 | 19,876 | 18,976 | 21,911 | 21,095 |
Operating Income Operating Income Growth | 4,384 | 3,916 | 3,682 | 2,950 | 4,441 | 7,341 |
Net Income Net Income Growth | 3,086 | 2,779 | 2,512 | 1,829 | 3,075 | 4,767 |
Earnings Per Share EPS Growth | 19.44 | 17.51 | 15.84 | 11.55 | 19.33 | 29.97 |
EPS Growth | 11.02% | 10.54% | 37.14% | -40.25% | -35.50% | 44.26% |
| Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Speciality Chemicals Speciality Chemicals Growth | 23,143 | 22,143 | 20,610 | 18,490 | 19,812 | 17,242 |
Nutrition & Health Solutions Nutrition & Health Solutions Growth | 8,554 | 7,904 | 7,480 | 6,801 | 5,512 | 7,673 |
Chemical Intermediates Chemical Intermediates Growth | 18,116 | 16,680 | 16,217 | 18,970 | 24,660 | 29,335 |
Inter Segment Inter Segment Growth | -3,308 | -2,846 | -2,530 | -2,904 | -2,257 | -4,757 |
Total Total Growth | 46,505 | 43,881 | 41,776 | 41,358 | 47,727 | 49,494 |
| Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Cash & Investments Cash & Investments Growth | 1,899 | 1,899 | 855.68 | 787.84 | 727.25 | 456.97 |
Total Debt Total Debt Growth | 7,918 | 7,918 | 7,638 | 7,402 | 4,067 | 2,378 |
Net Cash (Debt) Net Cash Growth | -6,019 | -6,019 | -6,782 | -6,615 | -3,340 | -1,921 |
Net Cash Growth | - | - | - | - | - | - |
Net Cash Per Share Net Cash Per Share Growth | -37.90 | -37.92 | -42.77 | -41.76 | -21.01 | -12.08 |
| Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Operating Cash Flow Operating Cash Flow Growth | - | 5,243 | 5,081 | 4,300 | 4,625 | 4,527 |
Capital Expenditures CapEx Growth | - | -2,994 | -3,658 | -5,684 | -4,814 | -2,301 |
Free Cash Flow Free Cash Flow Growth | - | 2,249 | 1,423 | -1,384 | -189.25 | 2,226 |
Free Cash Flow Growth | - | 58.05% | - | - | - | 162.69% |
| Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Gross Margin | 38.50% | 38.18% | 47.58% | 45.88% | 45.91% | 42.62% |
Operating Margin | 9.43% | 8.92% | 8.82% | 7.13% | 9.30% | 14.83% |
Pretax Margin | 8.83% | 8.43% | 8.23% | 6.47% | 9.15% | 14.32% |
Profit Margin | 6.64% | 6.33% | 6.01% | 4.42% | 6.44% | 9.63% |
FCF Margin | - | 5.13% | 3.41% | -3.35% | -0.40% | 4.50% |
| Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
| Period Ending | Aug '26 Aug 2, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Dividend Per Share Dividend Per Share Growth | 5.000 | 5.000 | 5.000 | 5.000 | 5.000 | 5.000 |
Dividend Per Share Growth | 0% | 0% | 0% | 0% | 0% | 1328.57% |
Dividend Yield | 0.68% | 0.92% | 0.78% | 1.12% | 1.43% | 1.16% |
| Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
| Period Ending | Aug '26 Aug 2, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
PE Ratio | 37.85 | 30.94 | 40.88 | 39.35 | 18.65 | 15.03 |
Forward PE | 27.62 | 24.82 | 32.85 | 21.94 | 12.11 | 14.25 |
P/FCF Ratio | 51.72 | 38.23 | 72.15 | - | - | 32.19 |
PS Ratio | 2.50 | 1.96 | 2.46 | 1.74 | 1.20 | 1.45 |